Quick Answer
Forte Biosciences, Inc. reported Shares Outstanding of 12.95 million shares for fiscal year 2025.
Forte Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 12.95M | +102.5% |
| 2024 | 6.39M | +339.9% |
| 2023 | 1.45M | -93.1% |
| 2022 | 21.00M | +42.3% |
| 2021 | 14.75M | +15.0% |
| 2020 | 12.83M | +508.6% |
| 2019 | 2.11M | -90.8% |
| 2018 | 23.00M | +15.7% |
| 2017 | 19.88M | +802.7% |
| 2016 | 2.20M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 12.52M | +757.8% | +2.0% |
| June 30, 2025 | 12.28M | -66.3% | +86.6% |
| March 31, 2025 | 6.58M | -81.9% | +2.9% |
| December 31, 2024 | 6.39M | +339.9% | +337.9% |
| September 30, 2024 | 1.46M | -96.0% | -96.0% |
| June 30, 2024 | 36.44M | +73.1% | +0.1% |
| March 31, 2024 | 36.39M | +73.3% | +2404.1% |
| December 31, 2023 | 1.45M | -93.1% | -96.0% |
- Forte Biosciences, Inc. showed an increase of +102.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, Forte Biosciences, Inc.’s shares outstanding has grown by 487.9% (from 2.20 million shares to 12.95 million shares).
- The most recent figure is from Forte Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: